Abstract
Nippon Shokubai is entering the business of producing active pharmaceutical ingredients (APIs) for peptide and nucleic acid drugs. The company will build a plant in Suita, Japan, where it opened an API synthesis lab last year. The facility will be able to produce APIs in quantities ranging from milligrams to kilograms. Nippon Shokubai, best known as the world’s largest producer of superabsorbent polymers used in diapers and sanitary pads, has a strategy to expand in the medical field over the next three years.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
